Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20936521 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL20936415 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL20915296 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL20915249 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL20915547 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL20915527 | 1.00 | GPR84 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| Acetic Acid SCHEMBL9277685 | 0.91 | GPR84 (0.45) | GPR84ACE2 | |
| SCHEMBL13349287 | 0.84 | — | — | |
| SCHEMBL6509578 | 0.83 | MAPT (0.37) | GPR84LMNAADH1BADH1CADH1A | |
| SCHEMBL18649822 | 0.83 | LMNA (0.33) | GPR84OPRM1LMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370762-B2 | Vinylarene derivative and application | SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CO., LTD. (CN) | 2022-06-28 | — | — | US | disclosed |
| US-9598367-B2 | Heterocyclic compounds as bromodomain inhibitors | ZENITH EPIGENETICS LTD. (CA) | 2017-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370762-B2 | Vinylarene derivative and application | IDO1, IDO2, INMT | GPR84 1929/4885OPRM1 1749/4885SPHK1 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.